These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 21953577)

  • 21. Unfolded p53 as a Marker of Oxidative Stress in Mild Cognitive Impairment, Alzheimer's and Parkinson's Disease.
    García S; Amor-Gutiérrez O; Palomares-Albarrán M; Toyos-Rodríguez C; Cuetos F; Martínez C; Costa-García A; Fernández-Sánchez MT; de la Escosura-Muñiz A; Novelli A
    Curr Alzheimer Res; 2021; 18(9):695-700. PubMed ID: 34789127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased plasma levels of phospholipid in Parkinson's disease with mild cognitive impairment.
    Li Z; Zhang J; Sun H
    J Clin Neurosci; 2015 Aug; 22(8):1268-71. PubMed ID: 26055959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is the functional decline of Parkinson's disease similar to the functional decline of Alzheimer's disease?
    Sabbagh MN; Silverberg N; Bircea S; Majeed B; Samant S; Caviness JN; Reisberg B; Adler CH
    Parkinsonism Relat Disord; 2005 Aug; 11(5):311-5. PubMed ID: 15886042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma SUMO1 Protein is Elevated in Alzheimer's Disease.
    Cho SJ; Yun SM; Lee DH; Jo C; Ho Park M; Han C; Ho Koh Y
    J Alzheimers Dis; 2015; 47(3):639-43. PubMed ID: 26401699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A registry-based, case-control investigation of Parkinson's disease with and without cognitive impairment.
    Papapetropoulos S; Ellul J; Polychronopoulos P; Chroni E
    Eur J Neurol; 2004 May; 11(5):347-51. PubMed ID: 15142230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relation of testosterone levels with fatigue and apathy in Parkinson's disease.
    Kenangil G; Orken DN; Ur E; Forta H; Celik M
    Clin Neurol Neurosurg; 2009 Jun; 111(5):412-4. PubMed ID: 19131155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of plasma endothelial lipase levels on cognitive impairment.
    Yun SM; Park JY; Seo SW; Song J
    BMC Psychiatry; 2019 Jun; 19(1):187. PubMed ID: 31216999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Mild cognitive impairment in Parkinson's disease].
    Wada K; Nakashima K
    Brain Nerve; 2012 Dec; 64(12):1365-75. PubMed ID: 23209063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased protein-conjugated acrolein and amyloid-β40/42 ratio in plasma of patients with mild cognitive impairment and Alzheimer's disease.
    Waragai M; Yoshida M; Mizoi M; Saiki R; Kashiwagi K; Takagi K; Arai H; Tashiro J; Hashimoto M; Iwai N; Uemura K; Igarashi K
    J Alzheimers Dis; 2012; 32(1):33-41. PubMed ID: 22751175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional capacity of Brazilian patients with Parkinson's disease (PD): relationship between clinical characteristics and disease severity.
    Barbieri FA; Rinaldi NM; Santos PC; Lirani-Silva E; Vitório R; Teixeira-Arroyo C; Stella F; Gobbi LT;
    Arch Gerontol Geriatr; 2012; 54(2):e83-8. PubMed ID: 21963176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Baseline predictors for progression 4 years after Parkinson's disease diagnosis in the De Novo Parkinson Cohort (DeNoPa).
    Mollenhauer B; Zimmermann J; Sixel-Döring F; Focke NK; Wicke T; Ebentheuer J; Schaumburg M; Lang E; Friede T; Trenkwalder C;
    Mov Disord; 2019 Jan; 34(1):67-77. PubMed ID: 30468694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diagnosis and therapy for neurocognitive disorders in Parkinson's disease].
    Lucza T; Karádi K; Komoly S; Janszky J; Kállai J; Makkos A; Kovács M; Weintraut R; Deli G; Aschermann Z; Kovács N
    Orv Hetil; 2015 Jun; 156(23):915-26. PubMed ID: 26027599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of COMT, MTHFR, and SLC19A1(RFC-1) polymorphisms with homocysteine blood levels and cognitive impairment in Parkinson's disease.
    Białecka M; Kurzawski M; Roszmann A; Robowski P; Sitek EJ; Honczarenko K; Gorzkowska A; Budrewicz S; Mak M; Jarosz M; Gołąb-Janowska M; Koziorowska-Gawron E; Droździk M; Sławek J
    Pharmacogenet Genomics; 2012 Oct; 22(10):716-24. PubMed ID: 22890010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Instrumental activities of daily living are impaired in Parkinson's disease patients with mild cognitive impairment.
    Pirogovsky E; Schiehser DM; Obtera KM; Burke MM; Lessig SL; Song DD; Litvan I; Filoteo JV
    Neuropsychology; 2014 Mar; 28(2):229-37. PubMed ID: 24417192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of performance-based measures of instrumental activities of daily living in nondemented patients with Parkinson's disease.
    Pirogovsky E; Martinez-Hannon M; Schiehser DM; Lessig SL; Song DD; Litvan I; Filoteo JV
    J Clin Exp Neuropsychol; 2013; 35(9):926-33. PubMed ID: 24074137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparison of cognitive functions and neuropsychiatric symptoms between patients with Parkinson's disease dementia and Alzheimer's disease].
    Tang Y; Ji XJ; Xing Y; Zuo XM; Zhou AH; Jia JP
    Zhonghua Yi Xue Za Zhi; 2013 Aug; 93(31):2459-62. PubMed ID: 24300264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cognitive impairment and BDNF serum levels.
    Siuda J; Patalong-Ogiewa M; Żmuda W; Targosz-Gajniak M; Niewiadomska E; Matuszek I; Jędrzejowska-Szypułka H; Lewin-Kowalik J; Rudzińska-Bar M
    Neurol Neurochir Pol; 2017; 51(1):24-32. PubMed ID: 28341039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma exosomal prion protein levels are correlated with cognitive decline in PD patients.
    Leng B; Sun H; Zhao J; Liu Y; Shen T; Liu W; Liu X; Tan M; Li F; Zhang J; Li Z
    Neurosci Lett; 2020 Apr; 723():134866. PubMed ID: 32109555
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reliability and validity of A Quick Test of Cognitive Speed for detecting early-stage dementia in elderly Japanese.
    Takahashi F; Awata S; Sakuma N; Inagaki H; Ijuin M
    Psychogeriatrics; 2012 Jun; 12(2):75-82. PubMed ID: 22712639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The pattern of cognitive-functional decline in elderly essential tremor patients: an exploratory-comparative study with Parkinson's and Alzheimer's disease patients.
    Frisina PG; Tse W; Hälbig TD; Libow LS
    J Am Med Dir Assoc; 2009 May; 10(4):238-42. PubMed ID: 19426939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.